血液凝固檢驗市場規模、佔有率、成長分析、按產品、按測試類型、按技術、按最終用戶 - 行業預測，2024-2031 年

2022年全球血液凝固檢驗市場規模為27.4億美元，預測期內（2024-2031年）複合年成長率為11.40%，從2023年的30.5億美元增至2031年的72.4億美元。美元。

受多種因素影響，全球血液凝固檢驗市場近年來持續成長。在心血管疾病、血液疾病和老年人口不斷增加的推動下，血液凝固檢查在診斷和監測與凝血相關的各種醫療狀況方面發揮著重要作用。此外，血友病和血管性血友病等血液疾病的盛行率不斷增加，大大推動了對血液凝固檢驗的需求。此外，外科手術和創傷的增加進一步增加了對準確、及時的凝血診斷的需求。然而，診斷產品和設備的嚴格監管要求正在影響新參與企業進入市場，因此遵守品質標準和監管核准對於市場參與企業至關重要。

目錄

介紹

• 這項研究的目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場危機與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價值鏈分析
• 價格分析
• Start-Ups分析
• 監管環境
• 專利分析
• 管道分析
• 成功的關鍵因素
• 市場吸引力指數
• 競爭程度
• 主要投資機會
• 生態系繪圖

依產品分類：血液凝固檢驗市場

• 市場概況
• 分析設備
• 消耗品

按測試類型：血液凝固檢驗市場

• 市場概況
• 凝血酶原時間
• 活化部份凝血活酵素時間
• D-二聚體測試
• 纖維蛋白原測試
• 其他（凝血酶時間、血小板功能檢查）

依技術分：血液凝固檢驗市場

• 市場概況
• 光凝
• 機械混凝
• 電化學混凝

依最終用戶分類：血液凝固檢驗市場

• 市場概況
• 醫院
• 臨床實驗室
• 居家照護環境
• 就地檢驗

按地區分類：血液凝固檢驗市場規模

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Abbott Laboratories
• Siemens Healthcare
• Roche Diagnostics
• Beckman Coulter
• Sysmex Corporation
• Ortho Clinical Diagnostics
• Stago
• Werfen
• DiaSys
• Cardinal Health
• Helena Laboratories
• Instrumentation Laboratory
• Diagnostica Stago
• Hyphen Biomed
• Alere Inc.
• CoaguSense
• Hemosonics
• Diagon
• ILine Microsystems
• Bio-Rad Laboratories

Global Coagulation Testing Market size was valued at USD 2.74 billion in 2022 and is poised to grow from USD 3.05 billion in 2023 to USD 7.24 billion by 2031, at a CAGR of 11.40% during the forecast period (2024-2031).

The global Coagulation Testing Market has experienced consistent growth recently, driven by various factors. Coagulation testing plays a crucial role in diagnosing and monitoring various medical conditions related to blood clotting, propelled by the increasing incidence of cardiovascular diseases, blood disorders, and a growing elderly population. Furthermore, the rise in the prevalence of blood disorders like hemophilia and von Willebrand disease has significantly fueled the demand for coagulation testing. Moreover, an increase in surgical procedures and trauma cases has further heightened the necessity for accurate and timely coagulation diagnostics. However, stringent regulatory requirements for diagnostic products and devices impact the market entry of new players, making compliance with quality standards and regulatory approvals essential for market participants.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Coagulation Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Coagulation Testing Market Segmental Analysis

The global coagulation testing market is segmented into product, test type, technology, end-user, and region. Based on product, the market is segmented into analyzer and consumables. Based on type, the market is segmented into Prothrombin Time, Activated Partial Thromboplastin Time, D-dimer Testing, Fibrinogen Testing, Others (Thrombin Time, Platelet Function Tests). Based on Technology, the market is segmented into optical coagulation, mechanical coagulation, electrochemical coagulation. Based on end-user, the market is segmented into, Hospitals, clinical laboratories, home care settings, point-of-care testing. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Drivers of the Global Coagulation Testing Market

The rising incidence of cardiovascular diseases, alongside a worldwide population that is aging, highlights the escalating need for coagulation testing as a vital diagnostic measure. Furthermore, improvements in diagnostic technology, such as optical and electrochemical coagulation testing methods, bolster the precision and speed of results, fostering their uptake across various healthcare environments.

Restraints in the Global Coagulation Testing Market

One of the main obstacles in the marketplace stems from the challenges of standardizing coagulation testing procedures, particularly due to variations in results among different laboratories and settings. These inconsistencies can create hurdles for healthcare professionals in accurately interpreting results, potentially compromising the overall reliability of coagulation testing.

Market Trends of the Global Coagulation Testing Market

The noticeable transition to factor-of-care coagulation testing is propelled by the demand for swift diagnostic solutions in emergency scenarios and outpatient settings. This shift is driven by the necessity for rapid decision-making and is bolstered by technological advancements enabling the creation of portable, user-friendly coagulation testing devices, thereby enhancing their integration across diverse healthcare settings.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Coagulation Testing Market by Product

• Market Overview
• Analyzer
• Consumables

Coagulation Testing Market by Test Type

• Market Overview
• Prothrombin Time
• Activated Partial Thromboplastin Time
• D-dimer Testing
• Fibrinogen Testing
• Others (Thrombin Time, Platelet Function Tests)

Coagulation Testing Market by Technology

• Market Overview
• Optical Coagulation
• Mechanical Coagulation
• Electrochemical Coagulation

Coagulation Testing Market by End-user

• Market Overview
• Hospitals
• Clinical Laboratories
• Home Care Settings
• Point-of-Care Testing

Coagulation Testing Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stago
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werfen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSys
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Instrumentation Laboratory
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagnostica Stago
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hyphen Biomed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CoaguSense
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemosonics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagon
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ILine Microsystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments